TABLE 4.
Antibiotic susceptibility of A. baumannii
| Strain | MIC (μg/ml)a |
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TIC | TIM | CAZ | CTX | FEP | ATM | IPM | CHL | TET | MIN | TIG | RIF | NOR | CIP | SXT | GEN | TOB | AMK | NET | |
| BM4454 | 8 | 12 | 6 | 4 | 3 | 16 | 0.25 | >256 | 32 | 0.75 | 3 | 2 | >256 | >32 | 0.064 | 6 | 4 | 8 | 16 |
| BM4587 | 6 | 8 | 4 | 3 | 0.75 | 12 | 0.19 | 96 | 1.5 | 0.064 | 0.094 | 1.5 | 1.5 | 0.094 | 0.094 | 1 | 0.75 | 4 | 1.5 |
| BM4665 | 2 | 4 | 3 | 4 | 8 | 6 | 0.5 | >256 | 3 | 0.125 | 1.5 | 1.5 | 12 | 0.5 | 0.125 | 12 | 16 | 64 | 64 |
| BM4666 | 16 | 12 | 12 | 6 | 2 | 32 | 0.19 | >256 | 8 | 0.19 | 0.38 | 3 | 4 | 0.38 | 0.25 | 1.5 | 1 | 6 | 1.5 |
| BM4667 | 12 | 12 | 8 | 4 | 1.5 | 32 | 0.25 | 96 | 3 | 0.064 | 0.125 | 2 | 1.5 | 0.125 | 0.25 | 1.5 | 1.5 | 4 | 2 |
| BM4668 | 24 | 16 | 16 | 8 | 3 | 48 | 0.25 | >256 | 8 | 0.125 | 0.5 | 3 | 4 | 0.38 | 0.5 | 1.5 | 2 | 8 | 2 |
| CIP 70-10 | 24 | 16 | 6 | 12 | 1.5 | 48 | 0.25 | 48 | 1 | 0.047 | 0.125 | 4 | 2 | 0.125 | 0.094 | 1.5 | 2 | 6 | 2 |
| AYE | >256 | >256 | >256 | >256 | >256 | >256 | 1 | >256 | 64 | 0.5 | 1.5 | 16 | >256 | >32 | >32 | >256 | 64 | 96 | 48 |
| BM4675 | >256 | >256 | >256 | >256 | 8 | 32 | 2 | >256 | 32 | 8 | 1.5 | >32 | >256 | >32 | >32 | 24 | 12 | 96 | 32 |
| BM4676 | >256 | >256 | >256 | 32 | 32 | 32 | >32 | 128 | 12 | 1 | 1.5 | 2 | 192 | 24 | 0.125 | >256 | 96 | >256 | 12 |
a
AMK, amikacin; ATM, aztreonam; CAZ, ceftazidime; CHL, chloramphenicol; CIP, ciprofloxacin; CLI, clindamycin; CTX, cefotaxime; ERY, erythromycin; FEP, cefepime; GEN, gentamicin; IPM, imipenem; MIN, minocycline; NET, netilmicin; NOR, norfloxacin; RIF, rifampin; SXT, co-trimoxazole; TET, tetracycline; TIC, ticarcillin; TIG, tigecycline; TIM, ticarcillin-clavulanic acid; TOB, tobramycin.